title: Rituximab seems to be a safer alternative in patients with active rheumatoid arthritis with tuberculosis.
abstract: Demonstrating the efficiency and safety of rituximab (Rtx) in the treatment of active rheumatoid arthritis (RA) and tuberculosis (TB). Two cases of RA with active TB were followed up to 3 years following the initiation of Rtx. The former case presented with a history of concomitant diagnosis of both RA and TB and the latest one, also diagnosed with RA and reactivation of TB developed during the anti-tumour necrosis factor treatment. After a sufficient time of follow-up, we have observed that Rtx seems to be safer and efficient in the treatment of active RA and TB.
authors: Department of Rheumatology, Gaziantep University, Gaziantep, Turkey. drpehlivan@hotmail.com
authors: Yavuz
authors: Y
authors: Pehlivan
authors: Bunyamin
authors: B
authors: Kisacik
authors: Vuslat Kecik
authors: VK
authors: Bosnak
authors: Ahmet Mesut
authors: AM
authors: Onat
mesh_terms: D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000995:Antitubercular Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D000069283:Rituximab; D014397:Tuberculosis, Pulmonary / Q000150:complications* / Q000188:drug therapy
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D000995:Antitubercular Agents; D000069283:Rituximab